Claudia Hui, Vice President, Investment Banking, joined Bloom Burton as an Analyst in May 2015. Claudia currently leads the strategic efforts at Bloom Burton in identifying and evaluating promising MedTech companies developing innovative technologies with high investment potential. She also conducts technical (scientific, clinical) and commercial due diligence and provides strategy consulting and monetization planning for healthcare companies across all sectors and stages of development.
Since 2017, Claudia has served as a member of the Intellectual Property Advisory Committee for AllerGen NCE Inc., the Allergy, Genes and Environment Network.
Claudia holds a PhD in Infection and Immunity and a Masters in Science in Physiology and Pharmacology, both from McMaster University, and a Bachelor of Science in Physiology from McGill University.
Previously, Claudia worked as a Contract Consultant at Bloom Burton while completing her PhD in Infection and Immunity at McMaster University, specializing in allergy and immunology. She obtained her Master’s degree in Physiology and Pharmacology from McMaster University, specializing in asthma, and her Bachelor of science in Physiology from McGill University.